A minimally invasive treatment termed percutaneous transluminal coronary angioplasty (PTCA), also known as percutaneous coronary intervention (PCI), is used to unblock stenosed or blocked coronary ...

Please provide your email address to receive an email when new articles are posted on . Teleflex’s percutaneous transluminal coronary angioplasty perfusion balloon catheter has received FDA 510(k) ...

The Percutaneous Transluminal Angioplasty Balloons Market was valued at US$ 2.1 Bn in 2022 and is projected to grow at a CAGR of 5.4% from 2022 to 2031, reaching more than US$ 3.5 Bn by 2031. Rising ...

The global percutaneous transluminal angioplasty (PTA) balloons market was valued at approximately US$ 2.1 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 5.4%, ...

“Unveiling Future Possibilities: An In-depth Exploration of the ‘Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market Trends from 2023 to 2032’ Report” Embark on an ...

Covidien's Fortrex percutaneous transluminal angioplasty balloon catheter--Courtesy of Covidien Covidien ($COV) today announced FDA 510(k) clearance for its Fortrex ...

Low-profile, high-pressure balloon offers physicians exceptional performance in a single platform for peripheral angioplasty procedures NATICK, Mass., Boston Scientific Corporation today announced the ...

Please provide your email address to receive an email when new articles are posted on . C.R. Bard has purchased Lutonix, manufacturer of a drug-coated percutaneous transluminal angioplasty balloon, ...

DUBLIN--(BUSINESS WIRE)--The "Global Percutaneous Transluminal Angioplasty (PTA) Market (2024 Edition): Analysis By Product Type (Balloon Catheters, Stents, Guidewires, Others), By Application, By End ...

Silver Spring, MD - AngioSculpt percutaneous transluminal angioplasty (PTA) scoring balloon catheters, manufactured by AngioScore, are subject to a class I US Food and Drug Administration (FDA) recall ...